Upgrade to SI Premium - Free Trial

Cytori Therapeutics, Inc. (CYTX) Tops Q2 EPS by 1c

August 8, 2012 4:45 PM
Cytori Therapeut
ics, Inc. (NASDAQ: CYTX) reported Q2 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $2.46 million.

For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.

Categories

Earnings